Tech Company Financing Transactions
Sirnaomics Funding Round
Value Measured Investment and private investors invested in a $10 million funding round for Sirnaomics. This VC investment round was recorded on 4/30/2016.
Transaction Overview
Company Name
Announced On
4/30/2016
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Value Measured Investment (Lead Investor)
Proceeds Purpose
The proceeds will be used to fund clinical development of its first-in-class anti-fibrosis programs and the company expects to enter Phase I clinical trial with its lead product candidate, STP705, early second half of 2016.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
401 Professional Dr. 280
Gaithersburg, MD 20879
USA
Gaithersburg, MD 20879
USA
Phone
Website
Email Address
Overview
Sirnaomics, Inc. is a biopharmaceutical company discovering and developing novel targeted therapeutics for critical human diseases by using RNA interference (RNAi) technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Lu
Chief Medical Officer
Michael Molyneaux
Chief Operating Officer
George Ji
Chief Scientific Officer
David Evans
Chief Technical Officer
Dmitry Samarsky
VP - Finance
Nigel Yip
VP - Human Resources
John Buergenthal
Browse more venture capital transactions:
Prev: 4/30/2016: FLX Bio venture capital transaction
Next: 4/30/2016: SparkFund venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs